as 07-11-2025 1:35pm EST
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | GOLDEN VALLEY |
Market Cap: | 3.8B | IPO Year: | 2018 |
Target Price: | $213.75 | AVG Volume (30 days): | 600.5K |
Analyst Decision: | Buy | Number of Analysts: | 12 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.17 | EPS Growth: | N/A |
52 Week Low/High: | $123.00 - $225.00 | Next Earning Date: | 08-04-2025 |
Revenue: | $840,111,000 | Revenue Growth: | 27.11% |
Revenue Growth (this year): | 20.61% | Revenue Growth (next year): | 17.32% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Rondoni John | INSP | See Remarks | May 19 '25 | Sell | $149.38 | 1,734 | $259,024.92 | 13,766 | |
McCormick Shawn | INSP | Director | May 1 '25 | Sell | $160.00 | 360 | $57,600.00 | 24,046 |
INSP Breaking Stock News: Dive into INSP Ticker-Specific Updates for Smart Investing
Argus Research
17 days ago
Simply Wall St.
21 days ago
Zacks
a month ago
Zacks
a month ago
StockStory
a month ago
Argus Research
a month ago
Simply Wall St.
a month ago
Zacks
a month ago
The information presented on this page, "INSP Inspire Medical Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.